This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.
Frankly Speaking CME 46

Podcast

New Treatment for Asthma - Frankly Speaking EP 46We will discuss the use of azithromycin as a therapeutic option for patients with persistent symptomatic asthma despite controller maintenance therapy with inhaled corticosteroids and a long-acting bronchodilator.
Guest: Alan Ehrlich MD


CME Information

0 Credits - Not for CME/CE Credit

Release Date: 12/11/2017

Expiration Date: 12/31/2099

Faculty Disclosures

Frank J. Domino, MD

Learn More


  

Resources

  1. Gibon PG et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. 2017 Aug 12;390(10095):659-668
  2. Johnston SL et al. Azithromycin for Acute Exacerbations of Asthma: The AZALEA Randomized Clinical Trial. JAMA Intern Med. 2016 Nov 1;176(11):1630-1637Global Initiative for Asthma. 

  3. Global Strategy for Asthma Management and Prevention. Revised 2016. http://ginasthma.org/2016-gina-report-global-strategy-for-asthma-management-and-prevention/




New Treatment for Asthma - Frankly Speaking EP 46